Form 4: Amgen EVP & CFO Peter H. Griffith Reports Acquisition of 10,338 Shares

Peter H. Griffith, EVP & CFO of Amgen, reports acquiring 10,338 shares of common stock on March 6, 2024.

Summary

• On March 6, 2024, Peter H. Griffith, the EVP & CFO of Amgen Inc., acquired 10,338 shares of Amgen's common stock.
• The shares were acquired directly.
• Following the transaction, Griffith beneficially owns 39,250 shares of Amgen common stock, which includes restricted stock units (RSUs) and dividend equivalents (DEs).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by an executive, which is neither overwhelmingly positive nor negative.

Positives

• The acquisition of shares by a high-ranking executive could be interpreted positively, signaling confidence in the company's future performance.

Industry Context

Executive stock ownership is a common practice in publicly traded companies like Amgen. It aligns the executive's interests with those of the shareholders.

Comparison to Industry Standards

• Executive stock ownership is a common practice across the pharmaceutical and biotechnology industries.
• Companies like Johnson & Johnson, Pfizer, and Merck also have similar equity compensation plans for their executives.
• The vesting schedules and types of equity awards (RSUs, stock options) are generally comparable to industry norms.

Stakeholder Impact

• The acquisition of shares by the CFO could be viewed positively by shareholders, potentially increasing investor confidence.

Key Dates